CV
CapsoVision, Inc. Common Stock
NASDAQ: CV · HEALTHCARE · MEDICAL DEVICES
$7.08
+10.62% today
Updated 2026-04-30
Market cap
$297.04M
P/E ratio
—
P/S ratio
21.92x
EPS (TTM)
$-1.03
Dividend yield
—
52W range
$3 – $15
Volume
0.3M
CapsoVision, Inc. Common Stock (CV) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$7.08
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -186.80%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.